ARCHIVES

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 17 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

In Brief: Olden Chosen To Head NIEHS; Cancer Panel To Discuss Cancer and Poverty On July 9

June 28, 1991

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007